The Pharmaceuticals initiative of Reliance Life Sciences is focused on developing Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDFs) for domestic and global markets in the categories of:

  • Oncology products
  • Hyaluronate Injection

Reliance Life Sciences markets Oncology APIs and formulated products.

The pharmaceutical products are manufactured in cGMP facilities:

Plant 3 - Kilo scale facility for Pharmaceutical APIs with containment facilities for oncology products.

Plant 5 - A manufacturing facility for hyaluronic acid formulations.

Plant 6 - A manufacturing facility for oncology formulations (oral solid dosages and injectibles).